Categories: Joint Venture

Metropolis Healthcare India Expands its Footprints to Mauritius


Hyderabad, October 21, 2014:
Metropolis Healthcare Ltd., The Pathology Specialist, today announced a joint venture with Bramser Corporation. The joint venture, Metropolis Brasmer Lab Services Mauritius Ltd will introduce pathology services of highest quality and global standards to the nation. To begin with Metropolis has one central laboratory with collection points across Mauritius, Madagascar, Seychelles & Reunion. The central laboratory is located on the premises of the Apollo Bramwell Hospital and pathology services will be available to patients in the hospital as well as the citizens of Mauritius.

Plans are to set up 25 collection points across these locations in the coming year, with a focus remaining on providing quality diagnostic facilities to this region. Metropolis Healthcare will be opening 5 collection points with immediate effect at Port Louis, Curepipe, Moka, Quatre Bornes & Rose-Hill, with 2 more laboratories coming up across Central Flacq & Black River in the next 3 months. Investments planned around the joint venture are in the region of 50 million Mauritian Rupees.

Speaking at the occasion of the joint venture, Ms. Ameera Shah, Managing Director & CEO said, “As India’s most respected chain of pathology laboratories, we are looking at 1000 tests being performed locally in Mauritius. We also have the advantage of offering 4500 tests with the best turnaround time. We would be the first and foremost in the Mauritius diagnostic industry to offer the widest test menu combined with the highest standard of quality at an affordable rate.”

Mr Claudio Feistritzer-Rawat, Director of Metropolis Bramser Lab Services Mauritius Ltd explained, “There is a growing need for quality diagnostics in Mauritius. Our understanding of the market, combined with Metropolis’ expertise in global healthcare diagnostics, we look to bridge that gap while ensuring affordability and quality.”

Close to 2000 kilometers of the coast of the Indian subcontinent, Mauritius was ranked 9th out of 183 economies recently by the World Bank on the parameter of ‘Ease of Doing Business’. One of the world’s top tourist destinations, Mauritius is crowded throughout the year, ensuring that at present strength, the country is underpowered as far as diagnostic facilities go. Metropolis Healthcare Ltd., with a presence in UAE, Sri Lanka, South Africa, Kenya and Ghana is thus an ideal fit to ensure that affordable quality diagnostics are available for and in the island nation. CCI Newswire

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

2 days ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

2 days ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

3 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

3 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

4 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

4 days ago